Virpax Pharmaceuticals Inc (NASDAQ:VRPX) currently has a daily average trading volume of 198.68K but it saw 9815369 shares traded in last market. With a market cap of 4.77M USD, the company’s current market price of $0.59 came falling about -4.42 while comparing to the previous closing price of $0.62. In past 52 weeks, the stock remained buoying in the range of price level as high as $7.19 and as low as $0.36. In the recent trading on the day, stock has struck highest price mark of $0.5822 while lowest mark touched by it was $0.72.
Taking a look at 20-day trading activity of Virpax Pharmaceuticals Inc (VRPX) gives us an average price of $0.6788, while its current price level is -91.80% below from 52-week high level whereas it is 62.68% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $0.6544 while that of 200 days or SMA-200 reads an average of $1.7091. A closer look into the stock’s movement over the week reveals that its volatility is standing at 16.62% during that period while stretching the period over a month that decreases to 12.59%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 42.36 which implies that the stock is in neutral territory.
Over the week, VRPX’s stock price is moving -8.52% down while it is -5.44% when we observe its performance for the past one month. Year-to-date it is -81.58% down and over the past year, the stock is showing a downside performance of -90.50%.
The latest quarterly earnings report issued by the company reported quarterly earnings per share (EPS) of -12.06 beaten by the consensus estimate of -3 for the same. The company is expected to be releasing its next quarterly report in December, for which analysts forecasted an EPS of 0 while estimate for next year EPS is 0.
Currently, Virpax Pharmaceuticals Inc’s total number of outstanding shares is 8.09M with 3.72% of that held by the insiders while 1.90% of its common stock has been owned by the institutions. Company’s return on equity (ROE) at -594.46%. Stock’s beta reads 1.04. Its return on asset (ROA) is -198.45% on average.
